Metabolic Brain Disease

, Volume 33, Issue 5, pp 1443–1457 | Cite as

Computational insights of K1444N substitution in GAP-related domain of NF1 gene associated with neurofibromatosis type 1 disease: a molecular modeling and dynamics approach

  • Ashish Kumar Agrahari
  • Meghana Muskan
  • C. George Priya DossEmail author
  • R. Siva
  • Hatem ZayedEmail author
Original Article


The NF1 gene encodes for neurofibromin protein, which is ubiquitously expressed, but most highly in the central nervous system. Non-synonymous SNPs (nsSNPs) in the NF1 gene were found to be associated with Neurofibromatosis Type 1 disease, which is characterized by the growth of tumors along nerves in the skin, brain, and other parts of the body. In this study, we used several in silico predictions tools to analyze 16 nsSNPs in the RAS-GAP domain of neurofibromin, the K1444N (K1423N) mutation was predicted as the most pathogenic. The comparative molecular dynamic simulation (MDS; 50 ns) between the wild type and the K1444N (K1423N) mutant suggested a significant change in the electrostatic potential. In addition, the RMSD, RMSF, Rg, hydrogen bonds, and PCA analysis confirmed the loss of flexibility and increase in compactness of the mutant protein. Further, SASA analysis revealed exchange between hydrophobic and hydrophilic residues from the core of the RAS-GAP domain to the surface of the mutant domain, consistent with the secondary structure analysis that showed significant alteration in the mutant protein conformation. Our data concludes that the K1444N (K1423N) mutant lead to increasing the rigidity and compactness of the protein. This study provides evidence of the benefits of the computational tools in predicting the pathogenicity of genetic mutations and suggests the application of MDS and different in silico prediction tools for variant assessment and classification in genetic clinics.


NF1 RAS-GAP domain K1444N (K1423N) Homology modeling Molecular dynamics simulation Variant classification 



I would like to thank VIT management for providing the facility, seed money, and platform to carry out the research. No conflict of interest exists.

Supplementary material

11011_2018_251_MOESM1_ESM.docx (128 kb)
ESM 1 (DOCX 128 kb)
11011_2018_251_MOESM2_ESM.docx (83 kb)
Supplementary Fig. 1 Ramachandran plot of native model RAS-GAP domain of NF1 protein obtained by RAMPAGE server. (DOCX 83 kb)
11011_2018_251_MOESM3_ESM.docx (948 kb)
Supplementary Fig. 2 Conservational analysis of residues of RAS-GAP domain of NF1 protein using the ConSurf server. (DOCX 948 kb)
11011_2018_251_MOESM4_ESM.docx (99 kb)
Supplementary Fig. 3 RMSD plot of RAS-GAP domain of NF1 protein (a) first run (b) second run (c) third run of 50 ns of simulation. (DOCX 99 kb)
11011_2018_251_MOESM5_ESM.docx (15 kb)
Supplementary Fig. 4 Analysis of secondary structure element contribution in native and K1444N mutant. (DOCX 15 kb)
11011_2018_251_MOESM6_ESM.docx (1009 kb)
Supplementary Fig. 5 Illustration of an explicit change in secondary structure conformation in native (blue) and mutant K1444N mutant (green) RAS-GAP domain of NF1 protein (a) 0 ns (b) 40 ns (c) 50 ns. Color magenta and red are representing the residue region in between 60 and 68 of native and mutant respectively, color yellow and cyan are representing the residue region in between 110 and 120 of native and mutant respectively. (DOCX 1009 kb)


  1. Abdel-Azeim S, Oliva R, Chermak E et al (2014) Molecular dynamics characterization of five pathogenic factor X mutants associated with decreased catalytic activity. Biochemistry 53:6992–7001. CrossRefPubMedGoogle Scholar
  2. Acharya V, Nagarajaram HA (2012) Hansa: an automated method for discriminating disease and neutral human nsSNPs. Hum Mutat 33:332–337. CrossRefPubMedGoogle Scholar
  3. Adjei AA (2001) Blocking oncogenic Ras signaling for cancer therapy. J Natl Cancer Inst 93:1062–1074. CrossRefPubMedGoogle Scholar
  4. Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249CrossRefPubMedPubMedCentralGoogle Scholar
  5. Agrahari A, George Priya Doss C (2015) Impact of I30T and I30M substitution in MPZ gene associated with Dejerine-Sottas syndrome type B (DSSB): a molecular modeling and dynamics. J Theor Biol 382:23–33. CrossRefPubMedGoogle Scholar
  6. Agrahari AK, Sneha P, George Priya Doss C et al (2017) A profound computational study to prioritize the disease-causing mutations in PRPS1 gene. Metab Brain Dis 33:589–600. CrossRefPubMedGoogle Scholar
  7. Agrahari AK, Kumar A, Siva R et al (2018) Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot–Marie-tooth disease: a computational study. J Theor Biol 437:305–317. CrossRefPubMedGoogle Scholar
  8. Ahmadian MR, Kiel C, Stege P, Scheffzek K (2003) Structural fingerprints of the Ras-GTPase activating proteins neurofibromin and p120GAP. J Mol Biol 329:699–710. CrossRefPubMedGoogle Scholar
  9. Ali SK, Sneha P, Priyadharshini Christy J et al (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35:2714–2724. CrossRefPubMedGoogle Scholar
  10. Andersen LB, Ballester R, Marchuk DA et al (1993) A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol Cell Biol 13:487–495. CrossRefPubMedPubMedCentralGoogle Scholar
  11. Ars E, Kruyer H, Morell M et al (2003) Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients. J Med Genet 40:e82. CrossRefPubMedPubMedCentralGoogle Scholar
  12. Arun D, Gutmann DH (2004) Recent advances in neurofibromatosis type 1. Curr Opin Neurol 17:101–105CrossRefPubMedGoogle Scholar
  13. Ashkenazy H, Erez E, Martz E et al (2010) ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res 38:W529–W533. CrossRefPubMedPubMedCentralGoogle Scholar
  14. Bairoch A, Apweiler R (1996) The SWISS-PROT protein sequence data bank and its new supplement TREMBL. Nucleic Acids Res 24:21–25. CrossRefPubMedPubMedCentralGoogle Scholar
  15. Ballester R, Marchuk D, Boguski M et al (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851–859. CrossRefPubMedGoogle Scholar
  16. Bendl J, Stourac J, Salanda O et al (2014) PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations. PLoS Comput Biol 10. CrossRefPubMedPubMedCentralGoogle Scholar
  17. Benz RW, Castro-Román F, Tobias DJ, White SH (2005) Experimental validation of molecular dynamics simulations of lipid bilayers: a new approach. Biophys J 88:805–817. CrossRefPubMedGoogle Scholar
  18. Bromberg Y, Rost B (2007) SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res 35:3823–3835. CrossRefPubMedPubMedCentralGoogle Scholar
  19. Capriotti E, Calabrese R, Casadio R (2006) Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 22:2729–2734. CrossRefPubMedGoogle Scholar
  20. Capriotti E, Fariselli P, Rossi I, Casadio R (2008) A three-state prediction of single point mutations on protein stability changes. BMC Bioinformatics 9:S6. CrossRefPubMedPubMedCentralGoogle Scholar
  21. Capriotti E, Altman RB, Bromberg Y (2013) Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics 14(Suppl 3):S2. CrossRefPubMedPubMedCentralGoogle Scholar
  22. Chakraborty S (2012) Enumerating pathways of proton abstraction based on a spatial and electrostatic analysis of residues in the catalytic site. PLoS One 7. CrossRefPubMedPubMedCentralGoogle Scholar
  23. Chakraborty S, Minda R, Salaye L et al (2011) Active site detection by spatial conformity and electrostatic analysis-unravelling a proteolytic function in shrimp alkaline phosphatase. PLoS One 6:e28470. CrossRefPubMedPubMedCentralGoogle Scholar
  24. Chen B, Li L, Ren W et al (2017) A novel missense mutation in the ALPL gene causes dysfunction of the protein. Mol Med Rep 16:710–718. CrossRefPubMedPubMedCentralGoogle Scholar
  25. Chin SL, Lu Q, Dane EL et al (2016) Combined molecular dynamics simulations and experimental studies of the structure and dynamics of poly-amido-saccharides. J Am Chem Soc 138:6532–6540. CrossRefPubMedGoogle Scholar
  26. Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: narrowing the GAP. Cell 104:593–604CrossRefPubMedGoogle Scholar
  27. Cruz FJ, Lopes JN, Calado JC, Minas da Piedade ME (2005) A molecular dynamics study of the thermodynamic properties of calcium apatites. 1. Hexagonal phases. J Phys Chem B 109:24473–24479. CrossRefPubMedGoogle Scholar
  28. DeClue JE, Cohen BD, Lowy DR (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A 88:9914–9918. CrossRefPubMedPubMedCentralGoogle Scholar
  29. Doss CGP, Sethumadhavan R (2009) Investigation on the role of nsSNPs in HNPCC genes--a bioinformatics approach. J Biomed Sci 16:42. CrossRefPubMedPubMedCentralGoogle Scholar
  30. Doss CGP, Chakraborty C, Chen L, Zhu H (2014) Integrating in silico prediction methods, molecular docking, and molecular dynamics simulation to predict the impact of ALK missense mutations in structural perspective. Biomed Res Int 2014:895831–895814. CrossRefPubMedGoogle Scholar
  31. Doss CGP, Alasmar DR, Bux RI et al (2016) Genetic epidemiology of Glucose-6-dehydrogenase deficiency in the Arab world. Sci Rep 6.
  32. Dunzendorfer-Matt T, Mercado EL, Maly K et al (2016) The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation. Proc Natl Acad Sci 113:7497–7502. CrossRefPubMedGoogle Scholar
  33. Efimov AV, Brazhnikov EV (2003) Relationship between intramolecular hydrogen bonding and solvent accessibility of side-chain donors and acceptors in proteins. FEBS Lett 554:389–393. CrossRefPubMedGoogle Scholar
  34. Elber R (2016) Perspective: computer simulations of long time dynamics. J Chem Phys 144:060901. CrossRefPubMedPubMedCentralGoogle Scholar
  35. Emmerich D, Zemojtel T, Hecht J et al (2015) Somatic neurofibromatosis type 1 (NF1) inactivation events in cutaneous neurofibromas of a single NF1 patient. Eur J Hum Genet 23:870–873. CrossRefPubMedGoogle Scholar
  36. Eswar N, Webb B, Marti-Renom MA, et al (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci Chapter 2:Unit 2.9. CrossRefGoogle Scholar
  37. Gottfried ON, Viskochil DH, Fults DW, Couldwell WT (2006) Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications. Neurosurgery 58:1–16CrossRefPubMedGoogle Scholar
  38. Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185:862–864. CrossRefPubMedGoogle Scholar
  39. Guex N, Peitsch MC, Schwede T (2009) Automated comparative protein structure modeling with SWISS-MODEL and Swiss-PdbViewer: a historical perspective. Electrophoresis 30(Suppl 1):S162–S173. CrossRefPubMedGoogle Scholar
  40. Gutmann DH, Boguski M, Marchuk D et al (1993) Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. Oncogene 8:761–769PubMedGoogle Scholar
  41. Hess B, Kutzner C, Van Der Spoel D, Lindahl E (2008) GRGMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435–447. CrossRefPubMedGoogle Scholar
  42. Hsueh Y-P (2012) From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation. J Biomed Sci 19:33. CrossRefPubMedPubMedCentralGoogle Scholar
  43. Hubbard RE, Kamran Haider M (2010) Hydrogen bonds in proteins: role and strength. In: Encyclopedia of life sciences. John Wiley & Sons, Ltd, ChichesterGoogle Scholar
  44. Huson SM, Compston DA, Clark P, Harper PS (1989) A genetic study of von Recklinghausen neurofibromatosis in south East Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26:704–711CrossRefPubMedPubMedCentralGoogle Scholar
  45. Kabsch W, Sander C (1983) Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 22:2577–2637. CrossRefPubMedGoogle Scholar
  46. Kim S, Jhong J-H, Lee J, Koo J-Y (2017) Meta-analytic support vector machine for integrating multiple omics data. BioData Min 10:2. CrossRefPubMedPubMedCentralGoogle Scholar
  47. Kiuru M, Busam KJ (2017) The NF1 gene in tumor syndromes and melanoma. Lab Investig 97:146–157CrossRefPubMedGoogle Scholar
  48. Klose A, Ahmadian MR, Schuelke M et al (1998) Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum Mol Genet 7:1261–1268. CrossRefPubMedGoogle Scholar
  49. Krawczak M, Ball EV, Fenton I et al (2000) Human gene mutation database-a biomedical information and research resource. Hum Mutat 15:45–51.<45::AID-HUMU10>3.0.CO;2-T CrossRefPubMedGoogle Scholar
  50. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1082. CrossRefPubMedGoogle Scholar
  51. Kumar A, Pintus F, Di Petrillo A et al (2018) Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer’s disease. Sci Rep 8:4424. CrossRefPubMedPubMedCentralGoogle Scholar
  52. Li Y, Bollag G, Clark R et al (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275–281. CrossRefPubMedGoogle Scholar
  53. Li C, Medvedev GA, Lee E-W et al (2012) Molecular dynamics simulations and experimental studies of the thermomechanical response of an epoxy thermoset polymer. Polymer (Guildf) 53:4222–4230. CrossRefGoogle Scholar
  54. Lovell SC, Davis IW, Arendall WB et al (2003) tructure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50:437–450. CrossRefPubMedGoogle Scholar
  55. Marrone A, Re N, Storchi L (2016) The effects of Ca2+ concentration and E200K mutation on the aggregation propensity of PrPC: a computational study. PLoS One 11:e0168039. CrossRefPubMedPubMedCentralGoogle Scholar
  56. Martin GA, Viskoohil D, Bollag G et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843–849. CrossRefPubMedGoogle Scholar
  57. McCulloch DG, Marks NA, McKenzie DR, Prawer S (1995) Molecular dynamics and experimental studies of preferred orientation induced by compressive stress. Nucl Inst Methods Phys Res B 106:545–549. CrossRefGoogle Scholar
  58. Morcos P, Thapar N, Tusneem N et al (1996) Identification of Neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Mol Cell Biol 16:2496–2503. CrossRefPubMedPubMedCentralGoogle Scholar
  59. Morgan KJ, Rowley MA, Wiesner SM et al (2007) The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells. Leuk Res 31:1115–1121. CrossRefGoogle Scholar
  60. Mosaeilhy A, Mohamed MM, George Priya Doss C et al (2017) Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Metab Brain Dis 32:1417–1426. CrossRefPubMedGoogle Scholar
  61. Nagarajan R, Chothani SP, Ramakrishnan C et al (2015) Structure based approach for understanding organism specific recognition of protein-RNA complexes. Biol Direct 10. CrossRefPubMedPubMedCentralGoogle Scholar
  62. Olatubosun A, Väliaho J, Härkönen J et al (2012) PON-P: integrated predictor for pathogenicity of missense variants. Hum Mutat 33:1166–1174. CrossRefPubMedGoogle Scholar
  63. Peltonen S, Kallionpää RA, Peltonen J (2017) Neurofibromatosis type 1 ( NF1 ) gene: Beyond café au lait spots and dermal neurofibromas. Exp Dermatol 26:645–648. CrossRefPubMedGoogle Scholar
  64. Poullet P, Lin B, Esson K, Tamanoi F (1994) Functional significance of lysine 1423 of neurofibromin and characterization of a second site suppressor which rescues mutations at this residue and suppresses RAS2Val-19-activated phenotypes. Mol Cell Biol 14:815–821. CrossRefPubMedPubMedCentralGoogle Scholar
  65. Rajasekaran R, Sudandiradoss C, Doss CGP, Sethumadhavan R (2007) Identification and in silico analysis of functional SNPs of the BRCA1 gene. Genomics 90:447–452. CrossRefPubMedGoogle Scholar
  66. Ratner N, Miller SJ (2015) A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer 15:290–301CrossRefPubMedPubMedCentralGoogle Scholar
  67. Réblová K, Kulhánek P, Fajkusová L (2015) Computational study of missense mutations in phenylalanine hydroxylase. J Mol Model 21:70. CrossRefPubMedGoogle Scholar
  68. Resat H, Straatsma TP, Dixon DA, Miller JH (2001) The arginine finger of RasGAP helps Gln-61 align the nucleophilic water in GAP-stimulated hydrolysis of GTP. Proc Natl Acad Sci U S A 98:6033–6038. CrossRefPubMedPubMedCentralGoogle Scholar
  69. Sanjeev A, Mattaparthi VSK (2017) Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity. J Biomol Struct Dyn 10:1–13Google Scholar
  70. Scheffzek K, Lautwein A, Kabscht W et al (1996) Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature 384:591–596. CrossRefPubMedGoogle Scholar
  71. Scheffzek K, Ahmadian MR, Kabsch W et al (1997) The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277:333–338. CrossRefPubMedGoogle Scholar
  72. Scheffzek K, Ahmadian MR, Wiesmüller L et al (1998) Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J 17:4313–4327. CrossRefPubMedPubMedCentralGoogle Scholar
  73. Sen S, Goluguri RR, Udgaonkar JB (2017) A dry transition state more compact than the native state is stabilized by non-native interactions during the unfolding of a small protein. Biochemistry 56:3699–3703. CrossRefPubMedGoogle Scholar
  74. Sherry ST (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29:308–311. CrossRefPubMedPubMedCentralGoogle Scholar
  75. Shihab HA, Gough J, Cooper DN et al (2013) Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 34:57–65. CrossRefPubMedGoogle Scholar
  76. Skinner RH, Bradley S, Brown AL et al (1991) Use of the Glu-Glu-Phe C-terminal epitope for rapid purification of the catalytic domain of normal and mutant ras GTPase-activating proteins. J Biol Chem 266:14163–14166PubMedGoogle Scholar
  77. Sneha P, George Priya Doss C (2016) Chapter seven – Molecular dynamics: New frontier in personalized medicine. In: Advances in protein chemistry and structural biology. 102:181–224Google Scholar
  78. Sohier P, Luscan A, Lloyd A et al (2017) Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors. Genes Chromosom Cancer 56:421–426. CrossRefPubMedGoogle Scholar
  79. Srinivasan E, Rajasekaran R (2017) Exploring the cause of aggregation and reduced Zn binding affinity by G85R mutation in SOD1 rendering amyotrophic lateral sclerosis. Proteins Struct Funct Bioinforma 85:1276–1286. CrossRefGoogle Scholar
  80. Tang H, Thomas PD (2016) Tools for predicting the functional impact of nonsynonymous genetic variation. Genetics 203:635–647CrossRefPubMedPubMedCentralGoogle Scholar
  81. Tavtigian SV, Deffenbaugh AM, Yin L et al (2006) Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43:295–305. CrossRefPubMedGoogle Scholar
  82. Teilum K, Olsen JG, Kragelund BB (2011) Protein stability, flexibility and function. Biochim Biophys Acta (BBA) - Proteins Proteomics 1814:969–976. CrossRefGoogle Scholar
  83. Teng S, Srivastava AK, Wang L (2010) Sequence feature-based prediction of protein stability changes upon amino acid substitutions. BMC Genomics 11:S5. CrossRefPubMedPubMedCentralGoogle Scholar
  84. Theobald DL, Wuttke DS (2008) Accurate structural correlations from maximum likelihood superpositions. PLoS Comput Biol 4:e43. CrossRefPubMedPubMedCentralGoogle Scholar
  85. Theos A, Korf BR (2006) Pathophysiology of neurofibromatosis type 1. Ann Intern Med 144:842–849CrossRefPubMedGoogle Scholar
  86. Thirumal Kumar D, George Priya Doss C (2017) Role of E542 and E545 missense mutations of PIK3CA in breast cancer: a comparative computational approach. J Biomol Struct Dyn 35:2745–2757. CrossRefPubMedGoogle Scholar
  87. Thirumal Kumar D, George Priya Doss C, Sneha P et al (2017) Influence of V54M mutation in giant muscle protein titin: a computational screening and molecular dynamics approach. J Biomol Struct Dyn 35:917–928. CrossRefPubMedGoogle Scholar
  88. Tina KG, Bhadra R, Srinivasan N (2007) PIC: Protein Interactions Calculator. Nucleic Acids Res 35:W473–W476. CrossRefPubMedPubMedCentralGoogle Scholar
  89. Upadhyaya M (2010) Neurofibromatosis type 1: diagnosis and recent advances. Expert Opin Med Diagn 4:307–322. CrossRefPubMedGoogle Scholar
  90. Upadhyaya M, Osborn MJ, Maynard J et al (1997) Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 99:88–92CrossRefPubMedGoogle Scholar
  91. Wakui N, Yoshino R, Yasuo N et al (2018) Exploring the selectivity of inhibitor complexes with Bcl-2 and Bcl-XL: a molecular dynamics simulation approach. J Mol Graph Model 79:166–174. CrossRefPubMedGoogle Scholar
  92. Welti S, D’Angelo I, Scheffzek K (2008) Structure and function of neurofibromin. In: Neurofibromatoses. KARGER, Basel, 16:113–128Google Scholar
  93. Wiesmuller L, Wittinghofer A (1992) Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in Escherichia coli and role of the conserved lysine residue. J Biol Chem 267:10207–10210PubMedGoogle Scholar
  94. Xu GF, O’Connell P, Viskochil D et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599–608. CrossRefPubMedGoogle Scholar
  95. Xu J, Ren Y, Ge W et al (2010) Molecular dynamics simulation of macromolecules using graphics processing unit. Mol Simul 36:1131–1140. CrossRefGoogle Scholar
  96. Yunoue S, Tokuo H, Fukunaga K et al (2003) Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras. J Biol Chem 278:26958–26969. CrossRefPubMedGoogle Scholar
  97. Zaki OK, Krishnamoorthy N, El Abd HS et al (2017) Two patients with Canavan disease and structural modeling of a novel mutation. Metab Brain Dis 32:171–177. CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Integrative Biology, School of Biosciences and TechnologyVellore Institute of TechnologyVelloreIndia
  2. 2.Department of Biomedical Sciences, College of Health and SciencesQatar UniversityDohaQatar

Personalised recommendations